Clinical Trial Update: Therapy of Niacin for Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating niacin as a therapy for rheumatoid arthritis. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: NOT_YET_RECRUITING